Product Information
EZETIMIBE-SIMVASTATIN 10-20 MG is a generic product labeled by Ascend Laboratories, LLC, priced at $0.3013 per EA under NDC 67877050890. Its NADAC has been published 429 times since Apr 11, 2018.
Strength
10; 20 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877050890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA209222On Market Since
12/24/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has been published 429 times since Apr 11, 2018, and over the history we have for it it has declined 88.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3013 per EA |
|---|---|
| All-time high | $2.6674 (Apr 11, 2018) |
| All-time low | $0.2954 (Dec 17, 2025) |
| 52-week high | $0.4025 |
| 52-week low | $0.2954 |
| Median price | $0.5942 |
| Average price | $0.9621 |
| Largest weekly change | +46.7% (Jun 19, 2024) |
| Weeks tracked | 429 |
| Tracking since | Apr 11, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-20 MG, manufactured by Ascend Laboratories, LLC, is $0.3013 per EA (NDC 67877050890), effective Jun 24, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-20 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has declined 88.7%. It has been tracked across 429 weekly CMS publications since Apr 11, 2018.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-20 MG?
Since Apr 11, 2018, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has ranged from a low of $0.2954 (Dec 17, 2025) to a high of $2.6674 (Apr 11, 2018), with a median of $0.5942 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-20 MG?
3 NADAC-published products share the same active ingredient, strength, and dosage form as EZETIMIBE-SIMVASTATIN 10-20 MG, but none are currently priced below it.
Who manufactures EZETIMIBE-SIMVASTATIN 10-20 MG?
EZETIMIBE-SIMVASTATIN 10-20 MG (NDC 67877050890) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification